Treatment of von Willebrand's Disease

N Engl J Med. 2004 Aug 12;351(7):683-94. doi: 10.1056/NEJMra040403.
No abstract available

Publication types

  • Review

MeSH terms

  • Aminocaproates / therapeutic use
  • Blood Component Transfusion
  • Deamino Arginine Vasopressin / administration & dosage
  • Deamino Arginine Vasopressin / adverse effects
  • Deamino Arginine Vasopressin / therapeutic use*
  • Factor VIII / chemistry
  • Factor VIII / physiology
  • Factor VIII / therapeutic use
  • Female
  • Hemophilia A / physiopathology
  • Hemophilia A / therapy
  • Hemostasis / physiology
  • Humans
  • Isoantibodies
  • Menorrhagia / etiology
  • Phenotype
  • Plasma*
  • Pregnancy
  • Pregnancy Complications, Hematologic / drug therapy
  • Tranexamic Acid / therapeutic use
  • von Willebrand Diseases / classification
  • von Willebrand Diseases / diagnosis
  • von Willebrand Diseases / physiopathology
  • von Willebrand Diseases / therapy*
  • von Willebrand Factor / chemistry
  • von Willebrand Factor / physiology*
  • von Willebrand Factor / therapeutic use

Substances

  • Aminocaproates
  • Isoantibodies
  • von Willebrand Factor
  • Tranexamic Acid
  • Factor VIII
  • Deamino Arginine Vasopressin